Advocate Group’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-6,477
Closed -$3.39M 123
2025
Q1
$3.39M Sell
6,477
-1,581
-20% -$808K 0.62% 60
2024
Q4
$4.08M Sell
8,058
-36
-0.4% -$20.5K 0.77% 53
2024
Q3
$4.73M Buy
8,094
+194
+2% +$110K 0.86% 50
2024
Q2
$4.02M Buy
7,900
+217
+3% +$106K 0.81% 54
2024
Q1
$3.8M Buy
7,683
+120
+2% +$61K 0.76% 57
2023
Q4
$3.98M Buy
7,563
+65
+0.9% +$34.7K 0.85% 53
2023
Q3
$3.78M Buy
7,498
+197
+3% +$97K 0.88% 52
2023
Q2
$3.51M Buy
7,301
+203
+3% +$99.3K 0.77% 53
2023
Q1
$3.35M Sell
7,098
-27
-0.4% -$13K 0.73% 55
2022
Q4
$3.78M Buy
7,125
+28
+0.4% +$14.8K 0.81% 52
2022
Q3
$3.58M Buy
7,097
+68
+1% +$35.8K 0.89% 46
2022
Q2
$3.61M Buy
+7,029
New +$3.53M 0.84% 47

Other funds holding UNH

Advocate Group's UNH Position: Q2 2025 in Review

Advocate Group sold out of UnitedHealth (UNH) in Q2 2025, closing a stake of 6,477 shares — an estimated $3.39M sold.

Advocate Group first reported a position in UNH in Q2 2022 and held it in 12 quarters. The position peaked at $4.73M in Q3 2024. 3,178 funds tracked by Wall St. Rank hold UNH as of Q2 2025.

  • Advocate Group reported no remaining UnitedHealth position as of Q2 2025 after selling out during the quarter.
  • Advocate Group sold 6,477 UnitedHealth shares in Q2 2025, an estimated $3.39M.
  • Advocate Group first reported a position in UnitedHealth in Q2 2022 and held it in 12 quarters.
  • Advocate Group's UnitedHealth position peaked at $4.73M in Q3 2024.
  • 3,178 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2025.

Based on Advocate Group's 13F filing for Q2 2025, filed 25 Jul 2025.